WO2001060326A3 - Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique - Google Patents

Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique Download PDF

Info

Publication number
WO2001060326A3
WO2001060326A3 PCT/FR2001/000471 FR0100471W WO0160326A3 WO 2001060326 A3 WO2001060326 A3 WO 2001060326A3 FR 0100471 W FR0100471 W FR 0100471W WO 0160326 A3 WO0160326 A3 WO 0160326A3
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
sesquiterpene lactone
pharmaceutical composition
composition containing
containing sesquiterpene
Prior art date
Application number
PCT/FR2001/000471
Other languages
English (en)
Other versions
WO2001060326A2 (fr
Inventor
Daniel Jean
Leon Cariel
Original Assignee
L M D
Daniel Jean
Leon Cariel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L M D, Daniel Jean, Leon Cariel filed Critical L M D
Priority to JP2001559424A priority Critical patent/JP2003522779A/ja
Priority to US10/204,018 priority patent/US20040115289A1/en
Priority to AU2001235706A priority patent/AU2001235706A1/en
Priority to EP01907830A priority patent/EP1255530A2/fr
Publication of WO2001060326A2 publication Critical patent/WO2001060326A2/fr
Publication of WO2001060326A3 publication Critical patent/WO2001060326A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne une composition, cosmétique ou à titre de médicament, destinée à une application topique. Selon l'invention, cette composition comprend à titre de principe actif au moins une lactone sesquiterpénique, comme par exemple l'hélénaline, la dihydrohélénaline, le parthénolide et la cnicine, ou un analogue des lactones sesquiterpéniques dans un milieu physiologiquement acceptable et approprié pour une application topique.
PCT/FR2001/000471 2000-02-18 2001-02-16 Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique WO2001060326A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001559424A JP2003522779A (ja) 2000-02-18 2001-02-16 セスキテルペンラクトン又はそのアナログを含有する育毛関連障害治療用化粧品又は医薬組成物とその調製方法
US10/204,018 US20040115289A1 (en) 2000-02-18 2001-02-16 Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair -growth related disorders, and preparation method
AU2001235706A AU2001235706A1 (en) 2000-02-18 2001-02-16 Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
EP01907830A EP1255530A2 (fr) 2000-02-18 2001-02-16 Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/02023 2000-02-18
FR0002023A FR2805158B1 (fr) 2000-02-18 2000-02-18 Composition cosmetique ou medicamenteuse contenant une lactone sesquiterpenique ou un analogue pour traiter les desordres lies a la croissance pilaire, et son procede de preparation.

Publications (2)

Publication Number Publication Date
WO2001060326A2 WO2001060326A2 (fr) 2001-08-23
WO2001060326A3 true WO2001060326A3 (fr) 2002-06-20

Family

ID=8847129

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/000471 WO2001060326A2 (fr) 2000-02-18 2001-02-16 Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique

Country Status (6)

Country Link
US (1) US20040115289A1 (fr)
EP (1) EP1255530A2 (fr)
JP (1) JP2003522779A (fr)
AU (1) AU2001235706A1 (fr)
FR (1) FR2805158B1 (fr)
WO (1) WO2001060326A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861293B1 (fr) * 2003-10-22 2008-10-17 Greenpharma Sas Composition pour prevenir ou traiter des affections resultant d'un processus de mort cellulaire comprenant une lactone sesquiterpenique
JP2008179540A (ja) * 2005-01-07 2008-08-07 Noevir Co Ltd 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤
WO2008075649A1 (fr) * 2006-12-20 2008-06-26 Mmt Co., Ltd. Boisson, aliment, alicament, composition médicinale et procédé destinés à favoriser la croissance capillaire
WO2008075466A1 (fr) * 2006-12-20 2008-06-26 Mmt Co., Ltd. Boisson, aliment, alicament, composition pharmaceutique et procédé destinés à favoriser la croissance capillaire
JP5714365B2 (ja) * 2011-03-11 2015-05-07 国立大学法人 東京大学 育毛及び発毛促進剤
KR101816159B1 (ko) * 2016-05-04 2018-01-08 주식회사 에이치피앤씨 이소알란토락톤을 유효성분으로 함유하는 탈모 방지 또는 발모 촉진용 조성물

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832343A (en) * 1971-09-22 1974-08-27 Sori Soc Rech Ind Process for obtaining an extract of arnica montana
FR2504009A1 (en) * 1981-04-17 1982-10-22 Yersin David Topical compsns. contg. arnica extract - together with camphor, menthol and surfactant for topical treatment of inflammations and infections
EP0428773A1 (fr) * 1987-07-31 1991-05-29 Dermatologic Research Corporation Traitement des maladies de peau avec de l'artémisinine et des dérivés
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
JPH05306231A (ja) * 1992-04-24 1993-11-19 Pola Chem Ind Inc 皮膚外用剤
US5384121A (en) * 1991-01-11 1995-01-24 Rhodes Technology Method for the extraction of sesquiterpene lactones
JPH1067621A (ja) * 1996-08-23 1998-03-10 Shiseido Co Ltd 養毛料
US5804206A (en) * 1997-03-06 1998-09-08 Bio-Botanica, Inc. Therapeutic composition and method for treating skin using Centipeda cunninghami extract
WO1998039018A1 (fr) * 1997-03-03 1998-09-11 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
WO1998055075A2 (fr) * 1997-06-04 1998-12-10 Regents Of The University Of Michigan Compositions et procedes permettant d'inhiber le photovieillissement de la peau
JPH1179948A (ja) * 1997-09-12 1999-03-23 Noevir Co Ltd 養毛剤及び毛髪用化粧料、並びに皮脂分泌抑制用皮膚外用剤
US6020365A (en) * 1997-07-03 2000-02-01 Paracure, Inc. Arglabin compounds and therapeutic uses thereof

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832343A (en) * 1971-09-22 1974-08-27 Sori Soc Rech Ind Process for obtaining an extract of arnica montana
FR2504009A1 (en) * 1981-04-17 1982-10-22 Yersin David Topical compsns. contg. arnica extract - together with camphor, menthol and surfactant for topical treatment of inflammations and infections
EP0428773A1 (fr) * 1987-07-31 1991-05-29 Dermatologic Research Corporation Traitement des maladies de peau avec de l'artémisinine et des dérivés
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
US5384121A (en) * 1991-01-11 1995-01-24 Rhodes Technology Method for the extraction of sesquiterpene lactones
JPH05306231A (ja) * 1992-04-24 1993-11-19 Pola Chem Ind Inc 皮膚外用剤
JPH1067621A (ja) * 1996-08-23 1998-03-10 Shiseido Co Ltd 養毛料
WO1998039018A1 (fr) * 1997-03-03 1998-09-11 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
US5804206A (en) * 1997-03-06 1998-09-08 Bio-Botanica, Inc. Therapeutic composition and method for treating skin using Centipeda cunninghami extract
WO1998055075A2 (fr) * 1997-06-04 1998-12-10 Regents Of The University Of Michigan Compositions et procedes permettant d'inhiber le photovieillissement de la peau
US6020365A (en) * 1997-07-03 2000-02-01 Paracure, Inc. Arglabin compounds and therapeutic uses thereof
JPH1179948A (ja) * 1997-09-12 1999-03-23 Noevir Co Ltd 養毛剤及び毛髪用化粧料、並びに皮脂分泌抑制用皮膚外用剤

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] IOCHKOVA ET AL.: "Burdock: chemical composition and possible applications in cosmetics", XP002153625, retrieved from STN Database accession no. 1991:614498 *
DATABASE CAPLUS [online] KERY ET AL.: "Application of supercritical extraction for prosucing biologically active non-volatile vegetable materials", XP002153627, retrieved from STN Database accession no. 1997:192266 *
DATABASE CAPLUS [online] WILLUHN: "Arnica flowers: Pharmacology, toxicology and analytics of the sesquiterpen lactones as their main active substances", XP002153624, retrieved from STN Database accession no. 1996:411581 *
DATABASE CAPLUS [online] XP002153626, retrieved from STN Database accession no. 1994:200171 *
DATABASE CAPLUS [online] XP002153628, retrieved from STN Database accession no. 1999:205543 *
DATABASE WPI Week 199820, Derwent World Patents Index; AN 1998-225142, XP002153629 *

Also Published As

Publication number Publication date
AU2001235706A1 (en) 2001-08-27
FR2805158B1 (fr) 2004-12-03
US20040115289A1 (en) 2004-06-17
EP1255530A2 (fr) 2002-11-13
WO2001060326A2 (fr) 2001-08-23
FR2805158A1 (fr) 2001-08-24
JP2003522779A (ja) 2003-07-29

Similar Documents

Publication Publication Date Title
WO2001058412A3 (fr) Extraits de residus de la production de vin
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
CA2326485A1 (fr) Compositions anticancereuses
AU2002239282A1 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
BG106030A (en) Pharmaceutical composition
CA2295035A1 (fr) Formulations pharmaceutiques contenant du voriconazole
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
WO2000041681A3 (fr) FORMULATIONS DE MEDICAMENTS CONTENANT UN OPIOIDE ET UN α-AGONISTE
WO2002000258A8 (fr) Compositions medicales de therapie angiogenique
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
WO1997004788A3 (fr) Utilisation de glycosides de calendula dans le traitement du psoriasis
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
WO2001060326A3 (fr) Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique
AU6571400A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
WO2003039437A3 (fr) Preparation pharmaceutique d'administration orale contenant du paclitaxel encapsule dans des liposomes
AU4929400A (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
AU2001274171A1 (en) Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
WO2001022917A8 (fr) Compositions effervescentes comportant du nimesulide
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
AU2001246631A1 (en) Cosmetic or pharmaceutical composition containing a sesquiterpene lactone
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
WO2002036105A3 (fr) Utilisation d'agents sequestrants de cortisol dans le cadre du traitement de troubles lies a l'hypercortisolemie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 559424

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001907830

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001907830

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10204018

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001907830

Country of ref document: EP